Enriching Patient Care With Data Driven Insights From Our AI Powered Recovery Intelligence Platform
Enriching Patient Care With Data Driven Insights From Our AI Powered Recovery Intelligence Platform
Enhance Opioid Use Disorder Treatment Through
Advanced AI Enabled Wearable Technology
Enhance Opioid Use Disorder Treatment Through Advanced
AI Enabled Wearable Technology
OpiAID - AI Powered Recovery Intelligence
How We Work With You To Better Help Your Patients In Recovery
1: Collect
Seamlessly merge information from other third-party sources with biometric patient information collected using commercially available wrist-worn devices to create a unified database on OpiAID's cloud-based platform.
2: Analyze
By harnessing the raw biometric data collected, OpiAID has pioneered proprietary algorithms capable of quantifying withdrawal symptoms and pinpointing instances of acute substance use*, all achieved through the convenience of easily accessible wrist-worn devices.
*Pending FDA Approval
3: Alert
By integrating OpiAID's data aggregation capabilities with advanced biometric alerts, clinicians receive valuable insights that support the creation of personalized treatment plans for their patients.
4: Community
In the future, through our mobile app, we will expand clinical and network support into the community. This will enable us to help patients gain a deeper understanding of their physical well-being by monitoring a structured recovery plan. Furthermore, the app will facilitate global communication with the patient's clinical care team and support network, thereby enhancing the safety and effectiveness of MAT treatment programs.
Transforming Treatment, Boosting Retention
Dedicated to improving the safety and effectiveness of MOUD Treatment (Medications for Opioid Use Disorder) for enhanced profitability.
Discover how OpiAID supports the treatment of OUD, increasing patient retention rates and optimizing billable opportunities to enhance profitability.
- OpiAID’s integrated EHR decision support tool simplifies the interpretation of patient data and enhances collaborative clinical decision-making.
- Real-time biometric insights facilitate the development of personalized treatment plans, leading to improved engagement and increased retention rates.
- The platform empowers clinicians to effectively provide just-in-time interventions throughout the patients recovery program, ensuring effective support at crucial moments.
- OpiAID utilizes cutting-edge, cloud-based data science solutions that leverage machine learning to transform data.
- The platform delivers actionable alerts and insights, strengthening existing technology and bolstering clinic support.
- OpiAID empowers clinics with the capability to monitor patients beyond clinic walls, leading to improved patient retention rates, safer induction processes*, and the utilization of additional billing codes that could contribute to enhanced clinic profitability.
*Pending FDA Approval
- OpiAID’s interpreted dashboard insights and clinically validated alerts support well-informed clinical decision-making.
- The implementation of Remote Physiologic Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) supports uninterrupted care, opening the door to additional billable opportunities and better patient outcomes.
- Enhanced patient outcomes and sustained engagement lead to a boost in revenue for clinics.
- SBIR Phase I – OpiAID’s initial research lead to a remarkable success in detecting acute use with 96.9% accuracy and quantifying withdrawal with 98% accuracy.
- SBIR Fast Track Phase 1 – this ongoing research is being done to satisfy the requirements leading to FDA clearance for OpiAID’s unique claims.
- SBIR Fast Track Phase 2 – Scheduled for the Summer of 2024
- OpiAID’s offering transcends traditional hardware or software; it harnesses the power of machine learning to convert data into actionable insights.
- This customized approach empowers clinics to cater to the distinctive needs of each patient, taking into account their physiological response to treatment. It also enables close monitoring of patients outside of the clinic, creating opportunities for a diverse range of billing codes associated with Remote Therapeutic Treatment (RTM) and Remote Physiologic Monitoring (RPM).
- OpiAID’s mission is to assist clinicians in providing high-quality care using a personalized MOUD Treatment protocols .
- This approach aligns with legitimate medical requirements, establishing the foundation for billable insurance codes associated with Remote Therapeutic Monitoring (RTM) and Remote Physiologic Monitoring (RPM).
For each patient retained in treatment a clinic earns $8400.00 annually. *
* Amount of reimbursement varies by state.
* OPT Billing (RPM)* $0.00 $600,000*
* Pending Regulatory Oversight and Billing Success
- Retention
- Buprenorphine Patients
- Annual Revenue
- OPT Billing (RPM)
- Increased Revenue
- 33%
- 150
- $1.26M
- $0.00
- $0.00
- 66%
- 300
- $2.52M
- $600,000
- $1,860,000
For each patient retained in treatment a clinic earns $8400.00 annually. *
* Amount of reimbursement varies by state.
* OPT Billing (RPM)* $0.00 $600,000*
* Pending Regulatory Oversight and Billing Success
- Retention
- Buprenorphine Patients
- Annual Revenue
- OPT Billing (RPM)
- Increased Revenue
- 33%
- 150
- $1.26M
- $0.00
- $0.00
- 66%
- 300
- $2.52M
- $600,000
- $1,860,000
Who we are
Our Mission:
At OpiAID, our mission is deeply rooted in recognizing the intrinsic and inherent value of each individual. We reject stigmatizing labels such as 'Addict' and instead embrace the term ‘our neighbors in recovery.' Committed to this ethos, we focus on pioneering technologies that empower our neighbors in recovery to safely navigate their journey towards wellness, ensuring that those in recovery find their way home at night. Through relentless innovation and research, we strive to enhance MOUD Treatment (Medications for Opioid Use Disorder), ensuring its safety and effectiveness for all.
What we do
Because We Love Our “Neighbors” in Recovery.
Our approach involves integrating existing data from clinics' Electronic Health Records (EHR) with biometric data captured from commercially available wrist-worn devices. We then apply advanced machine learning techniques to analyze this comprehensive dataset. The culmination of this process results in the presentation of actionable insights presented within a user-friendly decision support dashboard.
Why Choose Us
Redefining Treatment for Substance Dependence
We deliver timely and actionable data that supports clinical decision-making. Our focus on providing such data is geared toward achieving several key goals:
By offering clinicians the information they need when they need it, we strive to enhance the overall well-being and success of our neighbors in treatment. This is achieved by making just-in-time interventions possible, leading to improved retention in care.
Our data-driven insights can help clinics identify additional revenue opportunities, enabling them to optimize their financial performance.
Efficient and informed clinical decision-making can lead to cost savings for payors by ensuring increased retention and high-quality care for patients by avoiding the alternatives such as Acute ED visits and 28-day programs.
Our commitment is to empower healthcare providers, payors, and patients with the information necessary to drive positive changes in their treatment programs.
The OpiAID Platform:
Enhancing Patient Care Through Data-Driven Insights.
Powered by Our AI-Enabled Recovery Intelligence Platform
Integrated EHR Decision Tool
Effortlessly streamline patient data, enhance clinical decision-making, and boost claims opportunities by reducing administrative burdens.
Real-time Biometric Insights
Simplify data from devices, quantify withdrawal using biometrics, and empower clinicians with real-time insights for personalized treatment plans.
Integrated EHR Decision Tool
Remove claims opportunities by reducing administrative burdens. àUsing the data they already have to collect, Collate, and collect the data in a simple to interpret dashboard
Customized Data Science Solutions
Elevate clinic support with cutting-edge, cloud-based services. Utilize machine learning to turn data into actionable insights, fueling existing technology.
Real-time Biometric Insights
Simplify data from devices, quantify withdrawal using biometrics, and empower clinicians with real-time insights for personalized treatment plans.
Join the Movement:
OpiAID Making MOUD Better
Empowering MAT Providers: OpiAID is powered by machine learning tools, addressing the high dropout rate in MAT programs. We provide data-driven insights for improved clinical and operational decision-making, leading to increased patient retention and more profitable clinics.
Our impact
Achieving Results: Data-Driven Success from SBIR Phase I
Precision in Detection: OpiAID boasts a 92% accuracy in detecting acute use and a remarkable 90% accuracy in quantifying signs of withdrawal. Our platform ensures clinically valid alerts and remote physiologic monitoring, enhancing decision-making for clinics.
Our partners
